Drug recall · September 19, 2018
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO recall
Why: Defective Delivery System: Water ingress through the lower water cup sensor of the device.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709
- Lots / codes
Lot number a) 2101503, 2101507, 2101523, 2101532, 2101533, EXP 07/31/2019; 2101557, EXP 11/30/2019 b) Lot # 2101504, EXP 4/24/2021; 2101509, 2101522, EXP 5/8/2021; 2101531, EXP 5/15/2021; 2101534, EXP 6/10/2021; 2101543, EXP 6/14/2021; 2101558, EXP 7/26/2021
- Quantity
- 2801 devices
- Company
- United Therapeutics Corp., Durham, NC
- Distribution
- IL, PA
- Initiated
- August 14, 2018 · Voluntary: Firm initiated
- Classified
- September 12, 2018
- Reported
- September 19, 2018
- Ended
- October 30, 2019
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.